The latest report by IMARC Group, titled “Animal Parasiticides Market Report by Type (Ectoparasiticides, Endoparasiticides, Endectocides), Animal Type (Companion Animals, Livestock Animals), End User (Veterinary Clinics and Hospitals, Animal Farms, Home Care Settings), and Region 2024-2032“, The global animal parasiticides market size reached US$ 9.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.09% during 2024-2032.
Animal parasiticides are pharmaceutical products created to manage and control parasitic infest in animals. These infestations, caused by parasites like fleas, ticks, mites, and worms, can cause distress, sickness, and even death in animals. Parasiticides are essential for preserving the health and quality of life of pets, livestock, and other animals, helping perform at their best. Developed through careful research and formulation, these products target specific parasites while prioritizing animal and environmental safety. They come in different types, such as topical treatments, oral medications, and collars.
Animal Parasiticides Market Trends and Drivers:
The market is being influenced by a growing awareness among pet owners and livestock producers about the importance of parasite control in animals. As people become more informed about the health risks associated with parasites, there is a greater need for effective solutions to combat them. Another significant factor driving market growth is the of pet ownership, as more households are embracing pets as cherished members of their families. This rise in pet ownership leads to a higher demand for products that protect pets from parasitic infestations, thus boosting the market for companion animal parasiticides. Additionally, the global livestock industry plays a crucial role in driving the demand for animal parasiticides. With the world population on the rise, there is a greater need for efficient livestock production to meet the demand for animal products. To achieve this, managing livestock health becomes essential, with parasiticides playing a key role in preventing losses due to parasitic infections.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/animal-parasiticides-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Ectoparasiticides
- Endoparasiticides
- Endectocides
Breakup by Animal Type:
- Companion Animals
- Livestock Animals
Breakup by End User:
- Veterinary Clinics and Hospitals
- Animal Farms
- Home Care Settings
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Bimeda Group
- Boehringer Ingelheim GmbH
- Ceva Santé Animale
- Merck & Co. Inc.
- Norbrook Laboratories Limited
- PetIQ LLC
- Vetoquinol S.A.
- Virbac
- Zoetis Inc.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
